• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究氟喹诺酮法昔洛韦及其他七种抗菌药物对 114 株专性厌氧菌的活性。

Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria.

机构信息

Institute for Medical Microbiology and Epidemiology of Infectious Diseases, University of Leipzig, Leipzig, Germany.

MerLion Pharmaceuticals GmbH, Berlin, Germany.

出版信息

Int J Antimicrob Agents. 2014 Nov;44(5):420-3. doi: 10.1016/j.ijantimicag.2014.07.006. Epub 2014 Aug 19.

DOI:10.1016/j.ijantimicag.2014.07.006
PMID:25264128
Abstract

The activity of finafloxacin against 73 strains of the Bacteroides fragilis group, 10 other Gram-negative anaerobic rods and 31 Clostridium difficile strains was determined by the broth microdilution technique. The activity was compared with that of moxifloxacin, levofloxacin, ciprofloxacin, clindamycin, imipenem, piperacillin/tazobactam and metronidazole. MIC(50/90) values (minimum inhibitory concentration, in μg/mL, at which 50% and 90% of the isolates tested are inhibited, respectively) for finafloxacin for the different species were determined: B. fragilis group, 0.5/2; other Gram-negative rods, 0.06/0.25; and C. difficile, 4/16. Furthermore, the MICs against 11 selected B. fragilis strains were determined under acidic conditions and resulted in MIC(50/90) values for finafloxacin of 0.25/4 μg/mL. Thus, finafloxacin shows promising activity against several pathogenic species of anaerobes. Furthermore, finafloxacin has increased activity against selected B. fragilis strains under acidic conditions compared with activity at neutral pH.

摘要

采用肉汤微量稀释法测定了法氟沙星对 73 株脆弱拟杆菌群、10 株其他革兰阴性厌氧杆菌和 31 株艰难梭菌的活性。将其活性与莫西沙星、左氧氟沙星、环丙沙星、克林霉素、亚胺培南、哌拉西林/他唑巴坦和甲硝唑进行了比较。确定了法氟沙星对不同种属的 MIC(50/90)值(以 μg/mL 表示,分别为测试的 50%和 90%分离物被抑制的最小抑菌浓度):脆弱拟杆菌群为 0.5/2;其他革兰阴性杆菌为 0.06/0.25;艰难梭菌为 4/16。此外,还在酸性条件下测定了 11 株选定的脆弱拟杆菌株的 MIC,结果法氟沙星的 MIC(50/90)值为 0.25/4 μg/mL。因此,法氟沙星对几种致病性厌氧菌具有良好的活性。此外,与中性 pH 时的活性相比,法氟沙星在酸性条件下对选定的脆弱拟杆菌株的活性增加。

相似文献

1
Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria.研究氟喹诺酮法昔洛韦及其他七种抗菌药物对 114 株专性厌氧菌的活性。
Int J Antimicrob Agents. 2014 Nov;44(5):420-3. doi: 10.1016/j.ijantimicag.2014.07.006. Epub 2014 Aug 19.
2
Antianaerobic activity of a novel fluoroquinolone, WCK 771, compared to those of nine other agents.新型氟喹诺酮类药物WCK 771与其他九种药物的抗厌氧活性比较。
Antimicrob Agents Chemother. 2004 Aug;48(8):3188-92. doi: 10.1128/AAC.48.8.3188-3192.2004.
3
Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.428株革兰氏阳性和阴性厌氧菌对Bay y3118的敏感性及其对环丙沙星、克林霉素、甲硝唑、哌拉西林、哌拉西林-他唑巴坦和头孢西丁的敏感性比较。
Antimicrob Agents Chemother. 1993 Aug;37(8):1649-54. doi: 10.1128/AAC.37.8.1649.
4
Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.新型喹诺酮类药物加替沙星对从普通外科、血管外科、心胸外科和耳鼻喉科手术患者中分离出的需氧和厌氧微生物菌株的体外抗菌活性比较
J Antimicrob Chemother. 2005 Nov;56(5):872-8. doi: 10.1093/jac/dki348. Epub 2005 Sep 26.
5
Comparative antianaerobic activity of BMS 284756.BMS 284756的抗厌氧活性比较
Antimicrob Agents Chemother. 2001 Feb;45(2):589-92. doi: 10.1128/AAC.45.2.589-592.2001.
6
Activity of Delafloxacin and Finafloxacin against Mycoplasma hominis and Species.达氟沙星和萘甲唑啉对支原体和其他种属的活性。
Microbiol Spectr. 2022 Jun 29;10(3):e0009922. doi: 10.1128/spectrum.00099-22. Epub 2022 May 9.
7
Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria.莫西沙星体外对专性厌氧菌的比较活性
Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):228-32. doi: 10.1007/s100960050465.
8
Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes.法氟沙星对表现为正常菌落形态和小菌落变异表型的葡萄球菌的体外比较活性。
J Antimicrob Chemother. 2011 Dec;66(12):2809-13. doi: 10.1093/jac/dkr393. Epub 2011 Sep 21.
9
Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.新型氯氟喹诺酮BAY y 3118与环丙沙星、司帕沙星及其他抗菌药物相比,对厌氧菌的活性增强。
Antimicrob Agents Chemother. 1994 Jul;38(7):1671-4. doi: 10.1128/AAC.38.7.1671.
10
Susceptibility of 497 clinical isolates of gram-negative anaerobes to trovafloxacin and eight other antibiotics.497株革兰氏阴性厌氧菌临床分离株对曲伐沙星及其他八种抗生素的敏感性
J Chemother. 1999 Oct;11(5):349-56. doi: 10.1179/joc.1999.11.5.349.

引用本文的文献

1
Antibiotic Resistances of Clostridioides difficile.艰难梭菌的抗生素耐药性。
Adv Exp Med Biol. 2024;1435:169-198. doi: 10.1007/978-3-031-42108-2_9.
2
Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing.艰难梭菌耐药性的最新进展:耐药机制与药敏试验
J Clin Microbiol. 2017 Jul;55(7):1998-2008. doi: 10.1128/JCM.02250-16. Epub 2017 Apr 12.
3
Finafloxacin: first global approval.非那沙星:全球首次批准。
Drugs. 2015 Apr;75(6):687-93. doi: 10.1007/s40265-015-0384-z.